PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
+11.44%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$394M
AUM Growth
+$129M
(+49%)
Cap. Flow
+$73.6M
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
51.76%
Holding
117
New
22
Increased
24
Reduced
5
Closed
23
Top Buys
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
$23.7M |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$12.8M |
| 3 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$11.9M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$7.52M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$5.41M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.1M |
| 2 |
Gilead Sciences
GILD
|
$9.51M |
| 3 |
Smith & Nephew
SNN
|
$8.66M |
| 4 |
Baxter International
BAX
|
$5.25M |
| 5 |
Greenlane Holdings
GNLN
|
$4.13M |
Sector Composition
| 1 | Healthcare | 76.41% |
| 2 | Industrials | 2.67% |
| 3 | Consumer Staples | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRACU
26
DELISTED
Stable Road Acquisition Corp. Unit
SRACU
| $4.49M | 0.39% |
+435,850
| New | +$4.49M |
|
|
OTIC
27
DELISTED
Otonomy, Inc.
OTIC
| $4.37M | 0.38% |
1,140,163
+146,700
| +15% | +$562K |
|
28
Qiagen
QGEN
$10.3B
| $4.22M | 0.37% |
+117,674
| New | +$4.22M |
|
|
IMVTU
29
DELISTED
Immunovant, Inc. Units
IMVTU
| $4.05M | 0.36% |
+165,170
| New | +$4.05M |
|
30
Masimo
MASI
$8B
| $3.86M | 0.34% |
24,409
+4,310
| +21% | +$681K |
|
31
Standard BioTools
LAB
$497M
| $3.8M | 0.33% |
1,090,830
+590,830
| +118% | +$2.06M |
|
|
MNTA
32
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.23M | 0.28% |
+163,490
| New | +$3.23M |
|
33
TG Therapeutics
TGTX
$5.11B
| $3.08M | 0.27% |
277,639
-77,080
| -22% | -$856K |
|
34
Natera
NTRA
$23.1B
| $2.57M | 0.23% |
76,300
+46,300
| +154% | +$1.56M |
|
35
Rocket Pharmaceuticals
RCKT
$354M
| $2.48M | 0.22% |
+109,000
| New | +$2.48M |
|
36
Evolus
EOLS
$495M
| $2.38M | 0.21% |
+195,583
| New | +$2.38M |
|
37
Cabaletta Bio
CABA
$155M
| $2.16M | 0.19% |
+154,792
| New | +$2.16M |
|
38
Ardelyx
ARDX
$1.57B
| $2.05M | 0.18% |
272,605
+132,520
| +95% | +$995K |
|
39
KALA BIO
KALA
$102M
| $1.97M | 0.17% |
10,676
+4,013
| +60% | +$740K |
|
|
40
Greenlane Holdings
GNLN
$4.53M
| – | – |
-1
| Closed | -$4.13M |
|
|
DERM
41
DELISTED
Dermira, Inc.
DERM
| $1.67M | 0.15% |
+110,350
| New | +$1.67M |
|
42
Adaptive Biotechnologies
ADPT
$1.96B
| $1.62M | 0.14% |
+54,010
| New | +$1.62M |
|
43
Neurogene
NGNE
$285M
| $1.58M | 0.14% |
+6,409
| New | +$1.58M |
|
44
Stereotaxis
STXS
$264M
| $1.29M | 0.11% |
+244,103
| New | +$1.29M |
|
45
Savara
SVRA
$643M
| $1.29M | 0.11% |
+287,110
| New | +$1.29M |
|
46
uniQure
QURE
$985M
| $1.17M | 0.1% |
16,350
+1,350
| +9% | +$96.8K |
|
47
Alkermes
ALKS
$4.94B
| $1.1M | 0.1% |
+54,000
| New | +$1.1M |
|
|
AVDL
48
Avadel Pharmaceuticals
AVDL
$1.53B
| $823K | 0.07% |
109,000
-12,435
| -10% | -$93.9K |
|
49
Abeona Therapeutics
ABEO
$353M
| $802K | 0.07% |
+9,810
| New | +$802K |
|
|
AMRN
50
Amarin Corp
AMRN
$317M
| $740K | 0.07% |
+1,725
| New | +$740K |
|